Loading...
Accretion Pharmaceuticals Limited IPO Details – Price, Date, GMP & Analysis
Listed
SME
Price Range:
Rs.101.00
Issue Size:
Rs.29.75 Cr
Lot Size:
1 shares
Open Date:
May 14
Accretion Pharmaceuticals Limited IPO Overview
Bidding Dates
May 14 - May 16
Min Investment
₹101
Price Range
₹101.00
Issue Size
₹29.75 Cr
IPO DRHP Doc
Company Overview
Accretion Pharmaceuticals Limited, established in 2012, manufactures tablets, capsules, and healthcare products, offering contract manufacturing services. The company is ISO certified and operates a manufacturing unit in Ahmedabad, Gujarat, with a presence in over 20 countries. As of January 2025, it employs 83 staff members, including 4 Executive Directors.
IPO Timeline
Opens
May 14
Closes
May 16
Allotment
May 19
Refunds
May 20
Shares Credit
May 20
Listing
May 21
Opens
May 14
Closes
May 16
Allotment
May 19
Refunds
May 20
Shares Credit
May 20
Listing
May 21
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 12.14x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 4.28x | Oversubscribed |
| RII (Retail Individual Investors) | 10.54x | Oversubscribed |
| Total Subscription | 7.67x | Oversubscribed |
Last updated: May 16, 2025, 06:21 PM
Current GMP:
No Premium
Est. Listing:
Rs.101
Est. Gain:
0%
Star Rating:
★★★★★(1/5)
Financial Information
Financial Data Table
Detailed breakdown of financial metrics across years
| Financial Metric | 2024 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ₹27.05 Cr | ₹27.05 Cr | ₹20.58 Cr | ₹17.74 Cr |
| Net Worth | ₹5.35 Cr | ₹5.35 Cr | ₹3.84 Cr | ₹3.08 Cr |
| Profit After Tax | ₹3.88 Cr | ₹3.88 Cr | ₹0.1 Cr | ₹0.08 Cr |
| Reserves and Surplus | ₹1.35 Cr | ₹1.35 Cr | ₹0 Cr | ₹0 Cr |
| Revenue | ₹33.94 Cr | ₹33.94 Cr | ₹29.53 Cr | ₹22.58 Cr |
| Total Borrowing | ₹13.48 Cr | ₹13.48 Cr | ₹8.47 Cr | ₹7.61 Cr |
Financial data is visualized in the chart above
Strengths & Risks Analysis
Key Strengths
Competitive advantages and positive aspects
- Certified with ISO 9001:2015, 14001:2015, and 22000:2018 for quality and safety standards
- Operates both in-house manufacturing and contract/loan licensing for corporate clients
- Broad product range including tablets, capsules, syrups, ointments, and medicated cosmetics
- Strong financial growth with PAT up from ₹10.39 lakhs in FY23 to ₹387.53 lakhs in FY24
- Promoters and management have significant experience in pharmaceutical operations
IPO Details
Accretion Pharmaceuticals IPO Details
| Face Value | ₹10 per share |
| Fresh Issue | 29,46,000 shares (aggregating up to ₹29.75 Cr) |
| IPO Date | May 14, 2025 to May 16, 2025 |
| Issue Price | ₹101 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Listing Date | May 21, 2025 |
| Lot Size | 1,200 Shares |
| Share Holding Post Issue | 1,11,16,000 shares |
| Share Holding Pre Issue | 81,70,000 shares |
| Total Issue Size | 29,46,000 shares (aggregating up to ₹29.75 Cr) |
Accretion Pharmaceuticals IPO Reservation
Share Reservation Distribution
HNI (NII)
1,222,800 shares (41.51%)
Retail
1,222,800 shares (41.51%)
Anchor Investors
211,200 shares (7.17%)
Market Maker
147,600 shares (5.01%)
QIB
141,600 shares (4.81%)
Accretion Pharmaceuticals IPO Promoter Holding
| Share Holding Post Issue | 73.48% |
| Share Holding Pre Issue | 100.00% |
Accretion Pharmaceuticals IPO Listing Details
| ₹101 per share |
| ACCPL |
| INE0T8T01010 |
| May 21, 2025 |
Key Dates
Open Date:May 14
Close Date:May 16
Listing Date:May 21
